back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-10-31 13:14 Tx date 2024-10-28 |
$MDCX
Medicus Pharma Ltd. (formerly Interactive Capital Partners Corporation) |
Lavelle, Francis W.
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-25,000 vol |
25,000 | |
| Filed 2024-10-31 13:13 Tx date 2024-10-28 |
$MDCX
Medicus Pharma Ltd. (formerly Interactive Capital Partners Corporation) |
Lavelle, Francis W.
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-25,623 vol |
25,622 | |
| Filed 2024-07-26 20:29 Tx date 2024-06-28 |
$MDCX
Medicus Pharma Ltd. (formerly Interactive Capital Partners Corporation) |
Lavelle, Francis W.
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$2,490
+1,245 vol $2.00 each |
51,245 | |
| Filed 2024-07-26 20:27 Tx date 2024-06-28 |
$MDCX
Medicus Pharma Ltd. (formerly Interactive Capital Partners Corporation) |
Lavelle, Francis W.
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$100,000
+50,000 vol $2.00 each |
50,000 | |
| Filed 2024-07-26 20:26 Tx date 2023-09-29 |
$MDCX
Medicus Pharma Ltd. (formerly Interactive Capital Partners Corporation) |
Lavelle, Francis W.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-07-26 20:26 Tx date 2024-06-28 |
$MDCX
Medicus Pharma Ltd. (formerly Interactive Capital Partners Corporation) |
Lavelle, Francis W.
4 - Director of Issuer
Direct Ownership
|
10.00% Unsecured Convertible Notes due 2025
36 - Conversion or exchange
|
-$100,000 vol |
$0 | |
| Filed 2024-05-06 19:00 Tx date 2024-05-03 |
$MDCX
Medicus Pharma Ltd. (formerly Interactive Capital Partners Corporation) |
Lavelle, Francis W.
4 - Director of Issuer
Direct Ownership
|
10.00% Unsecured Convertible Notes due 2025
16 - Acquisition or disposition under a prospectus exemption
|
+$100,000 vol |
$100,000 | |
| Filed 2024-05-06 18:59 Tx date 2023-09-29 |
$MDCX
Medicus Pharma Ltd. (formerly Interactive Capital Partners Corporation) |
Lavelle, Francis W.
4 - Director of Issuer
Direct Ownership
|
10.00% Unsecured Convertible Notes due 2025
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-12-21 13:01 Tx date 2023-10-24 |
$MDCX
Medicus Pharma Ltd. (formerly Interactive Capital Partners Corporation) |
Lavelle, Francis W.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
50,000 | |
| Filed 2023-12-21 13:00 Tx date 2023-09-29 |
$MDCX
Medicus Pharma Ltd. (formerly Interactive Capital Partners Corporation) |
Lavelle, Francis W.
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|